Indirect comparison of EGFR exon 19 deletion versus EGFR exon 21 L858R mutation in TKI therapy cohort in terms of HR for PFS.
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://figshare.com/articles/dataset/_Indirect_comparison_of_EGFR_exon_19_deletion_versus_EGFR_exon_21_L858R_mutation_in_TKI_therapy_cohort_in_terms_of_HR_for_PFS_/1170315
下载链接
链接失效反馈官方服务：
资源简介：
aHR19/21 of TKI represents HR19 exon deletion/exon 21 L858R mutation in TKI therapy cohort.
Abbreviations: CI = confidence interval; EGFR = epidermal growth factor receptor; HR = Hazard ratio; PFS = progression-free survival; TKI = tyrosine kinase inhibitor.
Indirect comparison of EGFR exon 19 deletion versus EGFR exon 21 L858R mutation in TKI therapy cohort in terms of HR for PFS.
创建时间：
2014-09-15
